Article

Precision Medicine Treatment of Alzheimer’s Disease: Successful Randomized Controlled Trial

2025-12-30

Abstract excerpt

<h4>Background: </h4> There is a critical need for effective therapeutics for Alzheimer’s disease. However, the majority of previous clinical trials have pre-determined a single treatment modality, such as a drug candidate or therapeutic procedure, which may be unrelated to the primary drivers of the neurodegenerative process. Therefore, a personalized, precision medicine approach, with increased data set size to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 27ffdbcb-5da8-5eff-a0ea-a538c28b4e75
DOI: 10.20944/preprints202512.2694.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Precision Medicine Treatment of Alzheimer’s Disease: Successful Randomized Controlled TrialDOI 10.20944/preprints202512.2694.v1Read

Precision Medicine Treatment of Alzheimer’s Disease: Successful Randomized Controlled TrialSemantic proximity Read

Precision Medicine Approach to Alzheimer’s Disease: Successful Proof-of-Concept TrialSemantic proximity Read

Precision Medicine: Clarity for the Complexity of Dementia.Semantic proximity Read

Recent Insights into Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies.Semantic proximity Read

Exploring precision medicine by utilizing individual genetic information for the management of Alzheimer's disease.Semantic proximity Read

Novel Therapeutic Strategies for DementiaSemantic proximity Read

A multimodal intervention for Alzheimer’s disease results in multifaceted systemic effects reflected in blood and ameliorates functional and cognitive outcomesSemantic proximity Read

Formulating Treatment to Cure Alzheimer’s DementiaSemantic proximity Read

Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious UpdateSemantic proximity Read

Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of Life Improvements for Early Alzheimer’s Disease PatientsSemantic proximity Read

Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases.Semantic proximity Read

Disease‐modifying therapies in Alzheimer's diseaseSemantic proximity Read